HPF (Hydroxyphenyl Fluorescein) for Selective hROS Detection
2026-07-22
HPF (hydroxyphenyl fluorescein) is a highly selective fluorescent probe for detecting highly reactive oxygen species (hROS) such as hydroxyl radicals and peroxynitrite. Its specificity and strong fluorescence after oxidation make it a gold standard for intracellular oxidative stress visualization in research settings.
In Vitro Drug Response Evaluation: Innovations in Cancer Res
2026-07-21
The reference dissertation introduces a nuanced framework for evaluating anti-cancer drug responses in vitro, distinguishing between proliferative arrest and cell death metrics. This work informs the design of more precise assays and enhances interpretation of pharmacological interventions in cancer research.
PK/PD Analysis of Gamithromycin for Pasteurella multocida in
2026-07-21
Yang et al. provide a quantitative evaluation of Gamithromycin pharmacokinetics and pharmacodynamics in cattle using a tissue cage model of Pasteurella multocida infection. Their study establishes key AUC/MIC targets for bacteriostatic, bactericidal, and eradication effects, guiding evidence-based dosing strategies for respiratory disease management.
Tomivosertib Suppresses Spontaneous Activity in Human DRG Ne
2026-07-20
This study provides the first direct evidence that Tomivosertib, a selective MNK1/2 inhibitor, can rapidly and reversibly suppress pathological spontaneous activity in human dorsal root ganglion (DRG) neurons from radiculopathy patients. These findings highlight the translational potential of targeting the MNK-eIF4E pathway in neuropathic pain and establish a foundation for future clinical investigation.
GLI2 Drives Tumor Immune Evasion via WNT and Prostaglandin S
2026-07-20
The referenced study identifies GLI2 as a crucial regulator of tumor immune evasion and resistance to anti-PD-1 immunotherapy, acting through coordination of WNT ligand and prostaglandin signaling. These mechanistic insights provide a foundation for developing more effective combination strategies to overcome immunotherapeutic resistance in cancer.
Western Secondary Antibody Dilution Buffer: Precision in Mac
2026-07-19
Discover how Western Secondary Antibody Dilution Buffer advances protein detection in Western blot assays, enabling more precise study of macrophage-driven atherosclerosis. Explore unique assay strategies and practical insights not covered in standard protocols.
Y-27632 Dihydrochloride: Selective ROCK Inhibition in Resear
2026-07-18
Y-27632 dihydrochloride is a potent, selective ROCK inhibitor used extensively in cytoskeletal, stem cell, and cancer research. Its efficacy stems from nanomolar inhibition of ROCK1/2, high selectivity over related kinases, and proven utility in cell viability and invasion assays. Reliable, quantitative protocols and storage guidelines enable reproducible research outcomes.
Angiotensin Peptides and SARS-CoV-2 Spike–Receptor Interacti
2026-07-17
A recent study demonstrates that naturally occurring angiotensin peptides, including angiotensin 1/2 (1-6), can enhance the binding of the SARS-CoV-2 spike protein to its cellular receptors, particularly AXL. This finding not only advances the mechanistic understanding of COVID-19 pathogenesis but also highlights new considerations for cardiovascular and viral disease research.
Plant Cell Lysis Buffer for WB and IP: Optimized Protein Ext
2026-07-17
Unlock consistently high-yield, non-denaturing protein extraction from plant tissues and beyond with Plant Cell Lysis Buffer for WB and IP. This guide translates recent molecular oncology research into actionable workflows, troubleshooting, and protocol enhancements for Western blotting, immunoprecipitation, and advanced protein analyses.
Lithium-Driven Exosomal Wnt10a Secretion Boosts Osteogenesis
2026-07-16
This study uncovers how lithium enhances osteogenesis by promoting Rab11a-facilitated exosomal Wnt10a secretion and activating β-catenin signaling in bone mesenchymal stem cells (BMSCs). The findings reveal a mechanistic basis for lithium's role in bone regeneration and suggest new avenues for engineering BMSC-derived exosomes to improve bone repair.
KU-55933: ATM Kinase Inhibitor Workflows for DNA Damage Rese
2026-07-16
KU-55933 is a potent and selective ATM kinase inhibitor, empowering researchers to dissect DNA damage response, cell cycle arrest, and cancer cell proliferation with precision. This guide translates cutting-edge findings and practical protocols into actionable insights, optimizing experimental reproducibility for advanced cancer and genome stability studies.
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflow
2026-07-15
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides sensitive, specific detection of goat IgG in fluorescence-based immunodetection assays such as ICC, IHC, flow cytometry, and ELISA. It should be used only with goat primary antibodies and in workflows requiring Cy3 fluorescence, not for cross-species or non-immunodetection applications.
Catalpol’s Multi-Pathway Modulation: Strategic Insights for
2026-07-15
Catalpol, a natural iridoid glycoside, is redefining translational research across neuroprotection and metabolic disease by targeting convergent cellular pathways. This thought-leadership article integrates mechanistic advances with strategic protocol design, highlighting state-of-the-art evidence—including novel SIRT1-HIF-1α signaling insights in drug-induced liver injury—and provides actionable guidance for researchers seeking robust, reproducible results. By bridging emerging findings with practical considerations, and referencing APExBIO’s optimally formulated Catalpol, we chart a course for maximizing impact in complex disease models.
GW 6471: Dissecting PPARα Antagonism in Environmental Hepato
2026-07-14
Explore how GW 6471, a potent PPARα antagonist, empowers advanced cellular metabolism research and delineates hepatotoxic mechanisms in environmental toxicology. This in-depth analysis reveals unique insights into assay optimization and disease modeling strategies.
Predictive siRNA-Drug Codelivery: Netarsudil as a Model Agen
2026-07-14
This study introduces a quantitative approach to predict which ionizable drugs can complex and co-encapsulate siRNA in nanoparticles, with Netarsudil (AR-13324) validated as an effective example. The findings offer mechanistic insights and a practical framework for designing combination therapies targeting complex cellular pathways.
458 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page